RYH - Invesco S&P 500 Equal Weight Health Care ETF
| Assets | $810.59M |
| NAV | $280.48 |
| Expense Ratio | 0.40% |
| PE Ratio | 20.67 |
| Beta (5Y) | 0.89 |
| Dividend (ttm) | $1.32 |
| Dividend Yield | 0.47% |
| Ex-Dividend Date | Mar 22, 2021 |
| 1-Year Return | - |
| Trading Day | April 20 |
| Last Price | $280.78 |
| Previous Close | $279.99 |
| Change ($) | 0.79 |
| Change (%) | 0.28% |
| Day's Open | 279.53 |
| Day's Range | 279.75 - 281.47 |
| Day's Volume | 6,041 |
| 52-Week Range | 203.65 - 281.47 |
Fund Description
The investment seeks to track the investment results (before fees and expenses) of the S&P 500® Equal Weight Health Care Index (the underlying index). The fund generally will invest at least 90% of its total assets in the securities that comprise the underlying index. The underlying index is composed of all of the components of the S&P 500® Health Care Index, an index that contains the common stocks of all companies included in the S&P 500® Index that are classified as members of the health care sector, as defined according to the Global Industry Classification Standard (GICS). The fund is non-diversified.
| Asset Class Equity | Sector Biotech |
| Region North America | Inception Date Nov 1, 2006 |
| Exchange NYSEARCA | Ticker Symbol RYH |
| Index Tracked S&P 500 Equal Weight Health Care Index | |
Top 10 Holdings
16.88% of assets| Name | Symbol | Weight |
|---|---|---|
| Mettler-Toledo | MTD | 1.78% |
| IQVIA Holdings | IQV | 1.71% |
| West Pharmaceutical Services | WST | 1.70% |
| Danaher | DHR | 1.68% |
| Steris | STE | 1.68% |
| Align Technology | ALGN | 1.68% |
| ResMed | RMD | 1.66% |
| DexCom | DXCM | 1.66% |
| Bio-Rad Laboratories | BIO | 1.66% |
| Waters Corporation | WAT | 1.66% |
Dividends
| Ex-Dividend | Amount | Pay Date |
|---|---|---|
| Mar 22, 2021 | $0.325 | Mar 31, 2021 |
| Dec 21, 2020 | $0.319 | Dec 31, 2020 |
| Sep 21, 2020 | $0.278 | Sep 30, 2020 |
| Jun 22, 2020 | $0.399 | Jun 30, 2020 |
| Mar 23, 2020 | $0.325 | Mar 31, 2020 |
| Dec 23, 2019 | $0.321 | Dec 31, 2019 |
Vaccine news this week has failed to give the health-care sector a lift. Mark Newton of Newton Advisors shares three charts that put the move into context.
Market optimism was abound during Monday's trading session as ETF investors were awash in mostly green with the major indexes rallying off vaccine news. If the rally is real, than investors will want to...
The health care sector has taken its lumps this year. For much of 2019, the second-largest sector weight in the S&P 500 has been a laggard and, as just one example of that trend, Pfizer (NYSE: PFE) has ...
This healthcare ETF hits a new 52-week high. Are more gains in store for this ETF?
With markets at sky-high levels, JC O'Hara says health care could offer value. John Petrides likes Verizon.
Biotech stocks fall after Trump promises executive order drug prices
CNBC's Meg Tirrell reports on the dip in biotech stocks after President Donald Trump promised that an executive order on drug prices is coming.